NEURONAL PARANEOPLASTIC AUTOANTIBODIES PROFILE Test
Test Name: NEURONAL PARANEOPLASTIC AUTOANTIBODIES PROFILE Test
Components: Amphiphysin, CV2, PNMA2(Ma2/Ta), ANNA-1/Hu, ANNA-2/Ri, PCA-1/Yo
Price: 2110.0 AED
Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.
Report Delivery: Sample Mon through Sat by 9 am; Report Same day
Method: Immunoblot
Test type: Paraneoplastic Syndromes
Doctor: Oncologist
Test Department:
Pre Test Information: No special preparation required
Test Details:
The NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE test is a diagnostic test that helps identify the presence of specific autoantibodies in the blood that are associated with paraneoplastic neurological disorders (PNDs). PNDs are a group of rare neurological disorders that are often associated with cancer.
This test is typically ordered when a patient presents with neurological symptoms that cannot be explained by other causes and there is a suspicion of an underlying cancer. The test helps to identify autoantibodies that are associated with specific PNDs, such as anti-Hu, anti-Yo, anti-Ri, anti-Ma2, and anti-CV2.
The presence of these autoantibodies can provide valuable information for the diagnosis and management of PNDs. It can help guide further investigations, such as imaging studies and tumor marker tests, to identify the underlying cancer. It can also help in determining the appropriate treatment options and monitoring the response to treatment.
The test involves taking a blood sample from the patient, which is then sent to a laboratory for analysis. The laboratory uses various techniques, such as enzyme-linked immunosorbent assay (ELISA) and immunoblotting, to detect and identify the specific autoantibodies.
It is important to note that a positive result for these autoantibodies does not confirm the presence of a PND or cancer. Further evaluation and testing, including imaging studies and biopsies, may be necessary to confirm the diagnosis.
Overall, the NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE test is a valuable tool in the diagnosis and management of paraneoplastic neurological disorders. It helps identify specific autoantibodies associated with PNDs, which can guide further investigations and treatment decisions.
Test Name | NEURONAL PARANEOPLASTIC AUTOANTIBODIES PROFILE Test |
---|---|
Components | *Amphiphysin*CV2*PNMA2(Ma2/Ta) *ANNA-1/Hu*ANNA-2/ Ri*PCA-1/Yo |
Price | 2110.0 AED |
Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Shiprefrigeratedorfrozen. |
Report Delivery | Sample Mon through Satby 9 am;ReportSameday |
Method | Immunoblot |
Test type | Paraneoplastic Syndromes |
Doctor | Oncologist |
Test Department: | |
Pre Test Information | No special preparation required |
Test Details |
The NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE test is a diagnostic test that helps identify the presence of specific autoantibodies in the blood that are associated with paraneoplastic neurological disorders (PNDs). PNDs are a group of rare neurological disorders that are often associated with cancer. This test is typically ordered when a patient presents with neurological symptoms that cannot be explained by other causes and there is a suspicion of an underlying cancer. The test helps to identify autoantibodies that are associated with specific PNDs, such as anti-Hu, anti-Yo, anti-Ri, anti-Ma2, and anti-CV2. The presence of these autoantibodies can provide valuable information for the diagnosis and management of PNDs. It can help guide further investigations, such as imaging studies and tumor marker tests, to identify the underlying cancer. It can also help in determining the appropriate treatment options and monitoring the response to treatment. The test involves taking a blood sample from the patient, which is then sent to a laboratory for analysis. The laboratory uses various techniques, such as enzyme-linked immunosorbent assay (ELISA) and immunoblotting, to detect and identify the specific autoantibodies. It is important to note that a positive result for these autoantibodies does not confirm the presence of a PND or cancer. Further evaluation and testing, including imaging studies and biopsies, may be necessary to confirm the diagnosis. Overall, the NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE test is a valuable tool in the diagnosis and management of paraneoplastic neurological disorders. It helps identify specific autoantibodies associated with PNDs, which can guide further investigations and treatment decisions. |